10:53:46 EDT Sun 16 Jun 2024
Enter Symbol
or Name

Login ID:

Q:OLK - OPTION SYMBOL ROOT - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
OLK - Q9.924.59·25.249.924.85-0.17-0.7711.217,5592,51625.08  25.08  24.6626.01  14.1016:01:56Jun 1115 min RT 2¢

Recent Trades - Last 10 of 2516
Time ETExPriceChangeVolume

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-06-11 09:01U:OLKNews ReleaseNotice to attend the Extra General Meeting of Olink Holding AB (publ)
2024-06-06 02:00U:OLKNews ReleaseOlink(TM) Target 48 Immune Surveillance Panel - The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
2024-05-30 08:00U:OLKNews ReleaseResearchers Use Olink(TM) Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
2024-05-13 06:00U:OLKNews ReleaseOlink reports first quarter 2024 financial results
2024-04-19 16:05U:OLKNews ReleaseReport from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
2024-04-02 08:00U:OLKNews ReleaseOlink(TM) Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
2024-03-25 08:00U:OLKNews ReleaseOlink reports fourth quarter and full year 2023 financial results
2024-03-25 08:00U:OLKNews ReleaseOlink publishes 2023 annual report
2024-03-15 08:00U:OLKNews ReleaseNotice to attend the Annual General Meeting of Olink Holding AB (publ)
2024-03-08 08:00U:OLKNews ReleaseOlink announces change of date for Annual General Meeting
2023-11-15 07:01U:OLKNews ReleaseOlink reports third quarter 2023 financial results
2023-11-05 20:00U:OLKNews ReleaseNovogene Asia Pacific Middle East and Africa adopts Olink ‚ ® Explore HT technology to accelerate multi-omics research with next generation proteomics
2023-10-17 08:19U:OLKNews ReleaseThermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics
2023-10-05 16:25U:OLKNews ReleaseLandmark studies utilizing Olink ‚ ® Explore technology signal a new era for population-scale proteogenomics
2023-09-19 03:00U:OLKNews ReleaseAnnouncing the Olink ‚ ® Target 48 Mouse Cytokine Panel ¢ € “ the next generation in immunoassays designed to accelerate translational research.
2023-09-12 11:00U:OLKNews ReleaseEurofins Genomics adopts Olink ‚ ® technology to advance proteomics research and accelerate precision medicine programs
2023-08-29 08:01U:OLKNews ReleaseOlink to participate in September investor events
2023-08-09 07:00U:OLKNews ReleaseOlink reports second quarter 2023 financial results
2023-08-08 08:00U:OLKNews ReleaseBaylor College of Medicine Human Genome Sequencing Center adopts Olink ‚ ® Explore HT proteomics platform
2023-07-13 08:00U:OLKNews ReleaseOlink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference